For the Inventor, By the Inventor

Enter assignee name

Lexington, MA, United States of America

Autoimmune Inc.

USPTO Granted Patents = 32

CIPO Patents = 3

Trademarks = 1

Forward Citations = 1,001

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Howard L Weiner (31 out of 46 patents)

David A Hafler (28 out of 31 patents)

Zhengyi Zhang (6 out of 6 patents)

4. David E Trentham (5 out of 5 patents)

5. Ahmad Al-Sabbagh (4 out of 4 patents)

6. Ariel Miller (3 out of 4 patents)

7. George S Eisenbarth (3 out of 8 patents)

8. Mohamed Sayegh (3 out of 3 patents)

9. Charles B Carpenter (3 out of 4 patents)

10. Zhengi Zhang (3 out of 3 patents)

11. George Eisenberth (2 out of 2 patents)

12. Dale P DeVore (1 out of 36 patents)

13. Robert B Nussenblatt (1 out of 3 patents)

14. Alan G Palestine (1 out of 2 patents)

15. Anna Gunilla Sturrock (1 out of 1 patent)

Core Competencies:

Type 1 Diabetes

Collagen

Multiple Sclerosis

Myelin Basic Protein

T-Cell Proliferation

Autoantigens

Aerosol Administration

Tolerance Induction

Immunodominant Epitopes

Rheumatoid Arthritis

Bystander Suppression

32 patents: Sort by Forward Citations

1. 6703361 - Method of treating or preventing Type 1 diabetes by oral administration of insulin (2004-03-09),

2. 6645504 - Bystander suppression of type I diabetes by oral administration of glucagon (2003-11-11),

3. 6077509 - Peptide fragments of myelin basic protein (2000-06-20),

4. 6039947 - Peptides derived from immunodominant epitopes of myelin basic protein (2000-03-21),

5. 6036957 - Suppression of T-cell proliferation using peptide fragments of myelin (2000-03-14),

6. 6019971 - Treatment of autoimmune arthritis by oral administration of collagen (2000-02-01),

7. 5961977 - Method of treating or preventing autoimmune uveoretinitis in mammals (1999-10-05),

8. 5935577 - Treatment of autoimmune disease using tolerization in combination with (1999-08-10),

9. 5869093 - Treatment of immune diseases by oral administration of autoantigens (1999-02-09),

10. 5869054 - Treatment of multiple sclerosis by oral administration of autoantigens (1999-02-09),

11. 5858980 - Peptide fragments of myelin basic protein (1999-01-12),

12. 5858968 - Method of treating or preventing type 1 diabetes by oral administration (1999-01-12),

13. 5858364 - Pharmaceutical dosage form for treatment of multiple sclerosis (1999-01-12),

14. 5856446 - Method of treating rheumatoid arthritis with low dose type II collagen (1999-01-05),

15. 5849298 - Treatment of multiple sclerosis by oral administration of bovine myelin (1998-12-15),

Autoimmune Inc. is a biotechnology company based in Lexington, MA, specializing in the development of innovative therapies for autoimmune diseases. The organization focuses on harnessing advanced research methodologies to create targeted treatments that address the underlying mechanisms of these conditions. With a commitment to improving patient outcomes, Autoimmune Inc. engages in cutting-edge research and collaborates with various stakeholders in the healthcare sector to advance its therapeutic pipeline.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

32 Patents

#28 in Lexington, MA

#637 in Massachusetts

#10,593 in US

#20,660 in the World

Lexington, MA, United States of America

Autoimmune Inc.

Forward Citations = 1,001

16 inventors:

Howard L Weiner (31 out of 46 patents)

David A Hafler (28 out of 31 patents)

Zhengyi Zhang (6 out of 6 patents)

4. David E Trentham (5 out of 5 patents)

5. Ahmad Al-Sabbagh (4 out of 4 patents)

Please report any incorrect information to [email protected]

Loading…